SCHEMBL30937681

SCHEMBL30937681

Cc1ccc2c(c1F)CN(CC(=O)O)C(=O)N2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.42
▸ MMP13 P45452 1/20 0.42
▸ LMNA P02545 1/20 0.35
▸ KDM4E B2RXH2 4/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ CYP3A4 P08684 2/20 0.33
▸ RECQL P46063 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ GRIN2D O15399 1/20 0.32
▸ GRIN3B O60391 1/20 0.32
▸ GRIA1 P42261 1/20 0.32
▸ GRIA2 P42262 1/20 0.32
▸ GRIA3 P42263 1/20 0.32
▸ GRIA4 P48058 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2A Q12879 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ GRIN2C Q14957 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937524 0.86 ACE (0.44) ACEMMP13LMNAKDM4EALDH1A1
SCHEMBL30937712 0.86 ACE (0.43) ACEMMP13KDM4EALDH1A1CYP3A4
SCHEMBL30937672 0.82 ACE (0.41) ACEMMP13KDM4EALDH1A1CYP3A4
SCHEMBL31120591 0.78 ACE (0.45) ACEMMP13KDM4EALDH1A1CYP3A4
SCHEMBL30937651 0.78 ACE (0.53) ACEMMP13LMNAKDM4EALDH1A1
SCHEMBL30937691 0.74 ACE (0.43) ACEMMP13KDM4EALDH1A1CYP3A4
SCHEMBL30937732 0.72 ACE (0.44) ACEMMP13KDM4EALDH1A1CYP3A4
SCHEMBL30937538 0.72 PER2 (0.45) KDM4EALDH1A1CYP3A4HTTHPGD
SCHEMBL30937727 0.71 ACE (0.35) ACEMMP13LMNAKDM4EALDH1A1
SCHEMBL30937679 0.68 BRD4 (0.51) ACEMMP13KDM4EALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback